Dec 3 (Reuters) - Britain's FTSE 100 .FTSE index is
seen opening 14 points lower at 6,449 on Thursday,
according to financial bookmakers.
* ASTRAZENECA: AstraZeneca Plc AZN.L will likely get
results of its U.S. COVID-19 vaccine trial in late-January
and could potentially file for an emergency authorization,
the chief adviser for the U.S. government's Operation Warp
Speed program said on Wednesday. * GOLD: Gold rose to an over one-week high as the
dollar weakened on hopes of coronavirus vaccine roll-outs,
while investors also weighed the possibility of more U.S.
stimulus. * OIL: Oil prices fell as producers including Saudi
Arabia and Russia locked horns over the need to extend
record production cuts set in place in the first wave of
the COVID-19 pandemic. * The UK blue-chip index .FTSE closed 1.2% higher on
Wednesday as the sterling weakened on doubts of whether a
trade deal could be reached by Britain and the European
Union, while the UK's approval of a COVID-19 vaccine also
supported sentiment.
* UK CORPORATE DIARY:
Countryside Properties Plc CSPC.L FY earnings
Go Ahead Group GOG.L Trading update
AJ Bell Plc AJBA.L FY earnings
Caretech Holdings Plc CTH.L FY earnings
Paragon Banking Group Plc PAGPA.L FY earnings
Phoenix Group Holdings Plc PHNX.L Trading update
* For more on the factors affecting European stocks,
please click on: LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB